REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmalex Bulgaria AD (Bulgaria)

Main Activities: Research and Development in Nanotechnology
Full name: Pharmalex Bulgaria AD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Pharmalex Bulgaria AD is an enterprise located in Bulgaria, with the main office in Sofia. It operates in the Research and Development in Nanotechnology sector. The enterprise was incorporated on 2021. 81 (2023) employees currently work for Pharmalex Bulgaria AD. In 2022, the company reported a net sales revenue increase of 38.96%. Its’ total assets recorded a growth of 23.74%. Pharmalex Bulgaria AD’s net profit margin decreased by 1.05% in 2022.

Headquarters
17 11 Avgust Str., Oborishte Distr.
Sofia; Sofia - city; Postal Code: 1000

Contact Details: Purchase the Pharmalex Bulgaria AD report to view the information.

Basic Information
Total Employees:
Purchase the Pharmalex Bulgaria AD report to view the information.
Outstanding Shares:
Purchase the Pharmalex Bulgaria AD report to view the information.
Registered Capital:
Purchase the Pharmalex Bulgaria AD report to view the information.
Incorporation Date:
2021
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
24.5%
Purchase this report to view the information.
20%
Purchase this report to view the information.
4.5%
Company Performance
Financial values in the chart are available after Pharmalex Bulgaria AD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
38.96%
Total operating revenue
38.92%
Net Profit (Loss) for the Period
21.35%
Total assets
23.74%
Total equity
27.63%
Net Profit Margin
-1.05%
Return on Equity (ROE)
-2.45%
Quick Ratio
-0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?